DrugPatentWatch Database Preview

QUTENZA Drug Profile

« Back to Dashboard

When do Qutenza patents expire, and when can generic versions of Qutenza launch?

Qutenza is a drug marketed by Averitas and is included in one NDA. There is one patent protecting this drug.

This drug has sixteen patent family members in ten countries.

The generic ingredient in QUTENZA is capsaicin. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the capsaicin profile page.

Summary for QUTENZA

International Patents:	16
US Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	2
Bulk Api Vendors:	93
Clinical Trials:	19
Patent Applications:	8,624
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for QUTENZA
DailyMed Link:	QUTENZA at DailyMed

Generic Entry Opportunity Date for QUTENZA

NDA:

022395

Dosage:

PATCH;TOPICAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Medical Subject Heading (MeSH) Categories for QUTENZA

Antipruritics

Sensory System Agents

Synonyms for QUTENZA

(6E)-N-(4-Hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide #

(6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide

(6E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide

(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide

(E)-8-Methyl-N-vanillyl-6-nonenamide

(E)-8-Methyl-N-vanillyl-6-nonenamide(8cl)

(E)-Capsaicin

(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide

(E)-N-(4-Hydroxy-3-methoxybenzyl)

(e)-n-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide

(E)-N-[(4-hydroxy-3-methoxy-phenyl)methyl]-8-methyl-non-6-enamide

(E)-N-[(4-Hydroxy-3-methoxyphenyl)-methyl]-8-methyl-6-nonenamide

(E)-N-[(4-HYDROXY-3-METHOXYPHENYL)METHYL]-8-METHYL-6-NONENAMIDE

(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide

(E)8-methyl-N-vanillyl-6-Nonenamide

[(E)-N-(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide

1217899-52-9

404-86-4

4CH-016296

6-Nonenamide, (E)-

6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl

6-Nonenamide, 8-methyl-N-vanillyl-, (E)-

6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI)

6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (6E)-

6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)-

6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (6E)-

6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (E)-

8-Methyl-N-Vanillyl-6-Nonenamide

8-Methyl-N-vanillyl-6-nonenamide, (E)-

8-Methyl-N-vanillyl-6E-nonenamide

8-Methyl-N-vanillyl-trans-6-nonenamide

912457-62-6

AB00053098_12

AB00053098-11

AC-10114

AC1LU7K3

AC1Q46B3

Adlea

AJ-26667

AK113598

AKOS007930159

ALGRX 4975

AN-23437

Ausanil

Axsain

BBL027836

BDBM20461

BDBM86537

Bio-0615

Bitter orange extract 30%

BPBio1_001053

BRD-K37056290-001-01-1

BRD-K50590187-001-06-6

BRN 2816484

BSPBio_000957

BSPBio_001548

BSPBio_002917

BT000467

C06866

C18H27NO3

Capsaicin

CAPSAICIN (2444-46-4 NONIVAMIDE (SYNTHETIC CAPSAICIN))

Capsaicin (8-Methyl-N-vanillyl-6-nonenamide)

Capsaicin (in oleoresin of capsicum)

Capsaicin (JAN/USP)

Capsaicin (Natural)

Capsaicin (transdermal patch formulation, neuropathic pain)

Capsaicin [in oleoresin of capsicum]

Capsaicin [USAN]

Capsaicin [USP:INN]

Capsaicin Patch

Capsaicin, >=95%, from Capsicum sp.

Capsaicin, analytical standard

Capsaicin, certified reference material, TraceCERT(R)

Capsaicin, European Pharmacopoeia (EP) Reference Standard

Capsaicin, from Capsicum sp., >=50% (HPLC)

Capsaicin, from natural source

CAPSAICIN, NATURAL

Capsaicin, pharmaceutical secondary standard; traceable to USP, PhEur

Capsaicin, United States Pharmacopeia (USP) Reference Standard

Capsaicin(Qutenza)

CAPSAICINE

CAPSAICINOIDS

Capsicin

Capsicine

CAS_404-86-4

CAS-404-86-4

Caswell No. 158

CC0144

CCG-39908

CCRIS 1588

CHEBI:3374

CHEBI:94524

CHEMBL294199

Citrus Aurantium 30%

Citrus Aurantium Extract

CITRUS AURANTIUM PE

CJ-23980

CS-1518

D00250

D0U5CE

DB06774

depletes Substance P

DSSTox_CID_241

DSSTox_GSID_20241

DSSTox_RID_75455

DTXSID9020241

E-CAPSAICIN

EI-125

EINECS 206-969-8

EPA Pesticide Chemical Code 070701

epsilon-capsaicin

FEMA No. 3404

FT-0082538

GTPL2486

HMS1361N10

HMS1570P19

HMS1791N10

HMS1921H11

HMS1989N10

HMS2089N11

HMS2092D21

HMS2097P19

HMS2230O23

HMS3402N10

HMS3649N15

HMS501B16

HSDB 954

HY-10448

I01-2469

IDI1_000354

IDI1_034018

Isodecenoate

Isodecenoic acid vanillylamide

KS-5181

LMFA08020085

LP003278

LS-2138

M1149

MCULE-8056866140

MEGxp0_001448

MFCD00017259

Mioton

MLS002154049

MolPort-001-742-263

MR3H3

N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide

N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide, (E)-

N-(3-Methoxy-4-hydroxybenzyl)-8-methyl-6-nonenamide

n-(4-hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide

N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide

N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide

N-[(4-hydroxy-3-methoxyphenyl)methyl]-6E-8-methyl-nonenamide

N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide

N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide

N0C781

N1667

N735

NCGC00017337-02

NCGC00017337-03

NCGC00017337-04

NCGC00017337-05

NCGC00017337-06

NCGC00017337-07

NCGC00017337-08

NCGC00017337-09

NCGC00017337-10

NCGC00017337-11

NCGC00017337-12

NCGC00017337-13

NCGC00090853-01

NCGC00090853-02

NCGC00090853-03

NCGC00090853-04

NCGC00090853-06

NCGC00090853-07

NCGC00090853-08

NCGC00090853-09

NCGC00090853-10

NCGC00090853-11

NCGC00090853-12

NCGC00257869-01

NCI-C56564

neurotoxic

NGX 4010

NGX-1998

NGX-3781

NGX-4010

NGX-7325

Nonenamide, 8-methyl-N-vanillyl-, (E)-

Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8 -methyl-, (E)-

NSC 56353

NSC_2548

NSC-56353

NSC-757844

NSC56353

NSC757844

Pharmakon1600-01501128

Prestwick_204

Prestwick2_000879

Prestwick3_000879

RTC-030399

S07O44R1ZM

SBI-0052593.P002

SC-19636

SCHEMBL8085

SCHEMBL8086

SDCCGMLS-0066678.P001

SMP2_000337

SMR000718774

SPECTRUM1501128

Spectrum5_000538

SR-05000001861

SR-05000001861-6

SR-05000001861-9

ST057183

STL372889

Styptysat

TC-030399

TL8002946

TNP00277

Tox21_110817

Tox21_200315

TQ-1018

trans-8-Methyl-N-vanillyl-6-nonenamide

trans-8-Methyl-N-vanillylnon

trans-Capsaicin

trans-Capsaicin-d3

trans-N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide

Transacin

UNII-S07O44R1ZM

UPCMLD-DP092

UPCMLD-DP092:001

UPCMLD-DP092:002

Vanilloid

W-5044

YKPUWZUDDOIDPM-SOFGYWHQSA-N

ZINC1530575

Zostrix

ZOSTRIX (TN)

Zostrix HP

US Patents and Regulatory Information for QUTENZA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009		RX	Yes	Yes			Y

International Patents for QUTENZA

Country	Document Number	Estimated Expiration
Spain	2272827
Portugal	1039802
Denmark	1039802
Canada	2314326
European Patent Office	1316308
Denmark	1316308